Monocytes from tumor-bearing mice are fundamentally different from those in non–tumor-bearing mice, and SHP2 inhibition exerts cell-autonomous effects on these altered monocytes from tumor-bearing mice. This evidence concerns the gene PTPN11 and neoplasm.